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Abstract
Leukocytes must traverse inflamed tissues to effectively control local infection. Although motility
in dense tissues appears to be integrin-independent actin-myosin based, during inflammation
changes to the extracellular matrix (ECM) may necessitate distinct motility requirements. Indeed,
we found that T cell interstitial motility was critically dependent on RGD-binding integrins in the
inflamed dermis. Inflammation-induced deposition of fibronectin was functionally linked to
increased αv integrin expression on effector CD4+ T cells. Using intravital multi-photon imaging,
we found that CD4+ T cell motility was dependent on αv expression. Selective αv blockade or
knockdown arrested TH1 motility in the inflamed tissue and attenuated local effector function.
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tThese data show a context-dependent specificity of lymphocyte movement in inflamed tissues that
is essential for protective immunity.
Pathogen clearance requires effector T cells to migrate into inflamed tissues to locate the
infected microenvironment. The molecular mechanisms involved in the migration of
leukocytes into tissues via extravasation have been well characterized1. However, the
interactions controlling movement through peripheral tissues are less well understood.
Integrins play a vital role in leukocyte trafficking from blood into tissues. Chemokine-
mediated integrin activation leads to firm adhesion of leukocytes to the endothelium,
essential for tranendothelial migration. In contrast, leukocyte interstitial migration is thought
to be largely integrin-independent2. Migration studies using artificial collagen matrices or
confinement chambers suggest that the dense three-dimensional ECM scaffold supports the
use of non-adhesive, actin-based traction mechanisms by leukocytes3, 4. In the lymph node
(LN), T cells migrate along networks of fibroblastic reticular cells (FRCs) that express
integrin ligands ICAM-1 and VCAM-1 and chemokines CCL19 and CCL21. However,
motility is driven by chemokine-mediated chemotaxis/haptotaxis directly and does not
require integrins for adhesion5. Similarly, genetic ablation of all known integrins in DCs
failed to perturb DC migration in the LN or skin6. Thus, under a variety of conditions,
integrins appear to be largely dispensable for extravascular trafficking of leukocytes.
Inflammatory mediators and pathogens themselves modify ECM density and composition in
peripheral tissues which may dictate new requirements for leukocyte motility at sites of
inflammation7. T cells expressing distinct integrins accumulate in particular inflammatory
settings and in discrete tissues where integrin expression is thought to play a role in tissue-
specific homing8 and retention within the tissue9. In contrast to the situation in LNs, where
collagen fibers are coated by FRCs, T cells in non-lymphoid tissues such as the skin and
lung are directly exposed to collagen fibers and associated ECM components that could act
as guidance cues for movement through the interstitial space. The use of multiphoton
microscopy has enabled the visualization of leukocyte motility within peripheral tissues with
studies highlighting a close association between T cells and matrix fibers in skin, brain and
tumors10–16. Lymphocyte movement in the skin during delayed type hypersensitivity
showed a correlation between collagen-binding integrins on T cells and their migration
along fibers requiring calcium signaling by Kv1.3 potassium-channels14. During infection
with Toxoplasma in the brain, effector T cells also migrate along reticular fibers, although
the brain was largely devoid of infection-induced increases in collagen13. In many studies,
blockade of G protein-coupled receptor signaling attenuated leukocyte interstitial motility,
but it is not clear if this is due to blockade of chemotaxis/kinesis per se or the absence of
chemokine-induced integrin activation. Although neutrophil interstitial migration in the
mesentery was shown to be integrin dependent17, there have been no studies that directly
test the role of integrins in T cell motility within inflamed peripheral tissues.
Given the critical role that physical confinement plays in three-dimensional cell motility4
and the extent of inflammation-driven ECM remodeling, we addressed mechanisms of
interstitial motility of effector CD4+ T lymphocytes in the inflamed dermis. Inflammation
was associated with a reduction in the density of collagen fibers and with extensive
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tfibronectin deposition. Using intravital multiphoton microscopy (IV-MPM) we found that
effector CD4+ T cell movement within the inflamed dermis is integrin-dependent and the
expression of αv-integrins is essential for interstitial motility and pathogen clearance. Thus,
movement through inflamed interstitial tissue requires the coordinate expression of specific
integrins on effector T cells with ECM changes in the tissue.
Results
Inflammation-induced migration along ECM fibers
Analysis of T cell interstitial migration was performed in the inflamed and non-inflamed
dermis using intravital multiphoton microscopy (IV-MPM). Dermal location was assessed
using the second harmonic generation (SHG) to distinguish the collagen-rich dermis from
collagen-replete epidermis and from blood vessels using intravenous Texas-red dextran (Fig
1a, b). Cells were tracked over time in three-dimensional space using semi-automated
software. T cells in the non-inflamed dermis were identified by using CD4-Cre+ Stop-floxed
YFP mice (Gt(ROSA)26Sortm1(EYFP)Cos mice) (86% αβ+ T cells, the majority being CD4+
and Foxp3−, Supplementary Figure 1). In the steady state non-inflamed dermis T cells were
observed at low frequencies and were uniformly non-motile (Fig 1c). Average velocities for
dermal CD4+ T cells (predominantly αβ T cells) were 0.803 ± 0.05 SEM µm/min; noticeably
less than that observe for actively surveying dermal γδ T cells in the steady state (average
speeds of 2–5 µm/min)18, 19. For T cell migration in the inflamed dermis, we followed a
population of antigen-specific CD4+ T cells. Naïve CD4+ T cells from WT15 T cell receptor
(TCR)-transgenic mice20 were primed in vitro under TH1 differentiation conditions. Primed
cells were labeled with CFSE and transferred into naïve BALB/c mice that were immunized
in the ear dermis with cognate peptide emulsified in CFA. Kinetic analysis in the inflamed
dermis defined the peak of effector T cell accumulation in the tissue to be 3–4 days after
immunization (data not shown). Inflammation led to striking changes in dermal T cell
velocities (Fig 1c, Supplementary movie 1), consistent with previous models14, 21, 22. The T
cells exhibited no preferential directionality in their crawling patterns and the mean squared
displacement (MSD) of their crawling tracks increased linearly over time, suggesting that
these cells were not following a chemotactic gradient within the tissue (Fig 1d, e). T cells
crawled preferentially in the lateral plane (XY) of this tissue, with limited vertical (Z-axis)
translocation (Supplementary Fig 2). In vivo-primed effector cells were visualized using
donor T cells from a YFP-IFN-γ reporter mouse23 and revealed crawling velocities and
patterns similar to the adoptive transfer of in vitro-primed effector T cells (Fig 1f,
Supplementary Fig 3). Thus, inflammation drives the recruitment and interstitial motility of
effector T cells in the dermis. This enhanced T cell motility in the presence of inflammation
and/or microbial stimuli is in contrast to dermal dendritic cells that are motile in non-
inflamed dermis but immobile when exposed to microbial stimuli24 suggesting cell type-
specific cues for motility and arrest.
Imaging revealed dramatic changes in the collagen fibers of the inflamed skin, as visualized
by second harmonic generation (SHG) (Fig 2a). Compared to collagen structure in untreated
skin, characterized by dense layers of interwoven collagen fibers, the collagen in CFA-
inflamed skin was a loose network of thick collagen bundles (Fig 2a–c). The collagen fibers
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twere also preferentially oriented in the XY plane (Supplementary Fig 4). Many T cells
appeared to be crawling in directional patterns that closely followed the local collagen fibers
(Supplementary Fig 5, Supplementary movie 1). To test if there was preferential migration
of T cells along the matrix scaffold, we developed an unbiased quantitative technique that
utilized computational image analysis to compare frame-by-frame directional vectors of
individual T cell migration patterns with the orientation of the matrix fibers (Fig 2d, e).
Briefly, SHG images were translated into a map of discrete collagen fibers based on local
SHG intensity gradients (Supplementary Fig 5, and On-line methods). We then compared
the migratory directions of the T cells with directions of the “local” collagen fibers (those
fibers within a 6 µm radius around the T cell centroid) (Fig 2f) and calculated the angle
differences between the vectors representing the fibers and those representing the migrating
cell (Fig 2g). If T cells preferentially moved parallel to the local ECM fibers, we would
expect more observations in close alignment (small angle differences) between ECM fibers
and T cell migration than if T cell migration was random. This was indeed the case (Fig 2h).
We quantified the close alignment by calculating the fraction of observations with an angle
difference smaller than 15° or 30° between fiber and migrating T cell (n=10 experiments).
The fraction of closely aligned observations was significantly larger (p<0.0001) than would
be expected from random T cell movement (Fig 2i). We conclude that T cells preferentially
migrated in directions parallel to the local collagen structures, suggesting that T cells were
utilizing a form of contact guidance. These data are consistent with a haptokinetic model of
motility, in which cells migrate along a three-dimensional surface, interacting with bound
ligand through cell-surface receptors.
Integrin-dependent motility in the inflamed dermis
The density of the matrix appears to be a key determinant of the mode of interstitial motility,
with integrin-dependency increasing as the density of the matrix decreases4. Therefore, the
inflammation-based changes in collagen density and the crawling pattern of T cells along the
matrix fibers prompted us to revisit integrin-dependency for T cell interstitial migration.
While imaging T cell migration in the dermis we administered a blocking antibody to β1
integrin, a common receptor chain that pairs with various α-chains for binding to
extracellular matrix components25, 26. Soon after i.v. injection of anti-β1 all intradermal T
cells stopped migrating (Fig 3a,b) and adopted a rounded morphology (Supplementary Fig
6, Supplementary movie 2), consistent with a loss of adhesion to the surrounding matrix.
Blockade of LFA-1 (ICAM-binding) had no effect on interstitial motility (data not shown).
To confirm that β1 was necessary for motility in the inflamed skin, we analyzed T cells
genetically deficient in the β1-subunit, using OTII itgb1flox/flox CD4-Cre mice. β1-deficient
T cells displayed no functional defects in clonal expansion, cytokines, or tissue infiltration;
as previously noted27 (data not shown). However, in contrast to acute β1 blockade, β1-
deficient T cells showed no defects in migration within the dermal interstitium (Fig 3c,d).
The disconnect between acute blockade and genetic deficiency raised two possibilities: that
antibody treatment leads to migratory arrest through activating T cell signaling or that there
is genetic compensation. To test effects of anti-β1 signaling independent of receptor-ligand
blockade we treated effector T cells with antibody and monitored migration in vitro on β2-
dependent ICAM-1 and CXCL12 coated-plates (Supplementary Fig 7). Anti-β1 treatment
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tdid not lead to cell arrest, suggesting cross-linking β1 is not sufficient to halt migration. To
address redundancy/compensation, β3 appeared to be the likely alternative matrix-binding
integrin for lymphocytes. Indeed, anti-β3 Ab treatment halted migration by β1-deficient T
cells in the inflamed dermis, showing β3 can compensate in the genetic absence of β1 (Fig
3e), but not during acute β1-blockade (Fig 3a,b). Surprisingly, anti-β3 treatment also led to
acute migratory arrest of wild-type (WT) T cells (Fig 3f,g). Therefore, both β1 and β3
contribute to interstitial motility but neither is sufficient for full migration in WT T cells.
Consistent with the ability of both β1 and β3 integrins to bind the RGD sequence found in
many ECM components such as fibronectin, local administration of RGD peptides (but not
control RAD peptides) led to striking T cell migratory arrest (Fig 3h–j, Supplementary
movie 3). Thus, effector T cells require integrin-ECM interactions for T cell migration
within the inflamed dermal interstitium.
Selective αv-integrin dependency for dermal motility
β1 and β3 both pair with the α-subunit, αv, prompting us to analyze effector T cell α-subunit
usage in the inflamed dermis. We first monitored receptor expression on a synchronous
cohort of effector T cells through the adoptive transfer of naïve WT15 cells followed by
immunization with LACK-CFA (Fig 4a). Five days after cell transfer and immunization we
observed a restricted pattern of integrin expression on the effector T cells in the inflamed
dermis with effector T cells expressing α2, α4 and αv subunits, but little α1 and no α5 (Fig
4a). To rigorously test the role of these individual α-subunits in T cell motility we used
acute antibody blockade and IV-MPM imaging. We found a highly restricted requirement
for αv in effector T cell motility in the inflamed dermis (Fig 4b, c, Supplementary movie 4);
blockade of α1, α2, α1+α2, or α4 failed to arrest T cell motility. Thus, αvβ1 and αvβ3 appear
to be uniquely required for T cell interstitial motility. The finding that T cells may use both
αvβ1 and αvβ3 to migrate through the CFA-inflamed dermis suggests that αv expression may
be limiting: acute perturbations to either β-subunit reduces the surface pool of αv-integrins
below a threshold needed for migration.
Fibronectin is a primary substrate for αv integrins28. However, dermal fibronectin is sparse
in the steady state, non-inflamed tissue (Fig 4d29, 30). Analysis of CFA-inflamed tissue
sections revealed widespread increases in dermal fibronectin throughout the tissue (Fig 4d),
consistent with previous observations in humans and hamsters29–31. Co-staining for types I
and III collagen showed that fibronectin was closely associated with the interstitial collagen
fibers (Fig 4e and Supplementary Fig 8) as previously observed32. Thus, in the inflamed
dermis, dramatic changes in the collagen density are accompanied by increases in tissue
fibronectin, consistent with a role for the RGD-dependent αv-integrin in T cell motility.
Coordinate expression of integrins and ECM
We next asked if expression of αv was restricted to a particular inflammation or tissue type.
Robust expression of αv was seen in the dermis in numerous inflammatory settings
including a Th2 model of atopic or allergic inflammation and infection with the protozoa
Leishmania major (Fig 5a, b) in both C57BL/6 (TH1-dominated) and BALB/c mice (Th2
dominated) (data not shown) and also acute barrier disruption from tape stripping (Fig 5b).
Similarly, pathogen-induced inflammation in the lung (Influenza) and gut (H. polygyrus)
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tand autoimmune infiltrates in the diabetic pancreas all showed uniformly high expression of
αv on infiltrating CD4+ T cells. Therefore, αv expression on effector CD4+ T cells is
observed across tissues and inflammation types. To identify possible context-dependent
changes in T cell integrin expression we examined other matrix-binding α-integrin subunits.
Using an unbiased hierarchical clustering analysis of the frequency of integrin-expressing T
cells, T cells clustered into two principal groups based on tissue type (Fig 5b). Expression of
collagen-binding integrins, α1 and α2, were markedly different between tissues: α2 but not
α1 was expressed on effector CD4+ T cells in the skin under all inflammatory settings (Fig
5b) while effector T cells in the lung expressed high levels of both α1 and α2 (Fig 5c)9, 33. T
cells from the autoimmune inflamed pancreas segregated away from T cells in strong
microbial-induced inflammatory settings, expressing little α1 or α2.
To examine the relationship between T cell matrix-binding integrins and the type of ECM
components, we compared two examples of differential integrin expression and evaluated
collagen and fibronectin in the respective inflamed tissues (Fig 5d). As noted above, in the
CFA/OVA inflamed dermis αv was expressed by effector T cells and was critical for
motility (Fig 4a–c) consistent with co-localization of fibronectin and collagen fibers (Fig 4e,
5d). Expression of α2, but not α1, correlated with inflammation-induced expression of
collagens I and III (α2 ligands) but not collagen IV (α1 ligand) (Supplementary Fig 8). In
contrast, in the influenza infected lung (day 8 post-infection) high α1 and α2 expression by
effector T cells (Fig 5c) was associated with large areas of the lung parenchyma that were
rich in collagen III but low in fibronectin (Fig 5d, left panels) with extensive collagen IV
around blood vessels, airways and alveoli as described33. The collagen III rich areas were
coincident with the leukocytic infiltrates (Fig 5d, DIC image) and were not seen in
uninfected lungs (data not shown). Similarly, widespread T cell-collagen IV co-localization
was previously seen around the airways33. Thus, the co-expression of both α1 and α2 and αv
integrins may facilitate migration through distinct collagen-rich and fibronectin-rich regions
in the influenza-infected lung33.
αv-expression upregulated during T cell priming
αv expression was consistently higher on T cells in the inflamed dermis compared to the LN
(Fig 6a, Supplementary Fig 9). The regulation of matrix-binding integrins could occur
directly in the inflamed tissue through local induction or selection of integrin-expressing
effector T cells, or could be programmed during T cell activation in the LN, as seen for
tissue-specific homing molecules8, 34, 35. To explore these possibilities, we examined the
phenotype of activated T cells in the LN and in the inflamed tissue. Following intradermal
immunization, LN antigen-specific T cells segregated into three distinct populations based
on αv and CD62L expression, with the majority of CD62Llo cells expressing low levels of
αv (Fig 6a). In contrast, effector T cells that had migrated to the dermis were predominantly
αv
hiCD62Llo (Fig 6a). Cells expressing the highest amounts of activation markers CD25 and
glycosylated CD43 in the LN were preferentially αv
hi CD62Llo (Fig 6b). Blockade of LN
egress using the S1P1 receptor agonist, FTY720, led to a selective increase in the number of
αv
hiCD62Llo cells in the LN and a reciprocal loss of αv
hiCD62Llo cells in the inflamed
dermis (Fig 6c, d). Similar results were observed in a polyclonal CD4+ T cell response to
KLH/CFA and Leishmania major infection (Supplementary Fig 9). Thus effector CD4+ T
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tcells destined to exit the LN and patrol peripheral tissues express high amounts of αv
integrin and low CD62L, consistent with “emigrant” effector T cells36.
Essential role for αv integrin in interstitial migration and effector function
As seen in β1-deleted T cells (Fig 3), T cells genetically deficient in αv (OTII itgavflox/flox
CD4-Cre+) remained motile in the inflamed dermis but were still susceptible to migratory
arrest by RGD peptides (Fig 7a). Thus there appears to be a fundamental requirement for
integrin-mediated motility in inflamed tissues as highlighted by the high degree of
compensation following genetic ablation. To directly test the requirement for αv in
interstitial migration we turned to acute gene knock down using αv-specific shRNA. β1-
deficient OT-II T cells (whose motility remains αv-dependent, Fig 7b) were retrovirally-
transduced with a control vector or an αv-specific shRNA (Fig 7c) and transferred into
C57BL/6 congenic mice for imaging. Testing two shRNA constructs, αv-9 and αv-10, (see
Supplementary Fig 10 for αv-10 data) we found that knockdown of αv did not hinder
effector T cell recruitment to the inflamed dermis (Fig 7d) or change T cell location within
the tissue as both αv-sufficient and αv-deficient effector T cells could be found in the same
dermal regions (Fig 7e). However, the stable loss of αv (Fig 7c, f) significantly impaired the
motility of the interstitial T cells (Fig 7g, h, Supplementary Fig 10, Supplementary movie 5).
These data are especially remarkable because surface expression of αv was only reduced by
~60% (Fig 7c, f), indicating that only a fraction of the αv surface receptors need to be
compromised to alter migration, thus pointing to an essential role for αv integrins in T cells
interstitial migration within the inflamed dermis.
To determine the functional significance of αv expression we used both gene knockdown
and antibody blockade approaches. OVA-specific β1-deficient effector TH1 cells were
transduced with control or αv-9 shRNA expressing retrovirus and transferred to C57BL/6
congenic mice immunized with OVA/CFA. Both control vector and αv-9 shRNA GFP+
expressing T cells homed to the inflamed dermis with similar frequency (Fig 7i) and number
(Fig 7d). To determine ‘in vivo’ function, cells were harvested from tissues in buffers
containing Brefeldin-A to block cytokine secretion and intracellularly stained for IFN-γ,
without additional in vitro stimulation37, 38. Knockdown of αv had no effect on the
frequency of ex vivo IFN-γ-producers in the dLN (mean: 3,500 GFP+ IFN-γ producers,
control vector; 3,540 GFP+ IFNγ producers, αv-9 shRNA) highlighting αv-deleted T cells
are competent to make IFN-γ. Nonetheless, a reduction in T cell αv expression led to a
marked reduction in the frequency of IFN-γ-producers in the inflamed dermal tissue (Fig 7i).
Thus, T cell interstitial motility is dependent on αv and disruption of interstitial motility
limits T cell effector function, as represented here by IFN-γ production, presumably by
limiting their ability to encounter antigen-bearing APCs in the inflamed tissue. Clearance of
the protozoa L. major is critically dependent on IFN-γ-production by CD4+ T cells localized
to the infected dermis. Therefore, to test if the reduction in IFN-γ production might impact
on pathogen clearance, we infected WT mice with the protozoa L. major and administered
blocking anti-αv antibody. Anti-αv or control antibody was administered 4 weeks after L.
major infection, for a 3 week period, when the C57BL/6 mice are mounting a protective
IFN-γ-dependent anti-parasite immune response. As with shRNA knock-down, antibody
blockade of αv did not limit the generation of anti-Leishmania T cells in the LN (similar
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tIL-4/IFNγ ratio in all C57BL/6 groups, data not shown) or limit the number of CD4+ T cells
and macrophages that accumulated at the infection site (Fig 7j). However, blocking αv had a
significant impact on the ability to clear the pathogen (Fig 7k); with αv blockade leading to
significantly higher parasite titers. Attenuated pathogen clearance is consistent with the
reduced ability of T cells to mount an efficient IFN-γ–response. However, we cannot
exclude alternative mechanisms such as an effect of αv-blockade on macrophage
localization or function. Our studies find that integrin-dependent interstitial motility is
essential for efficient IFN-γ effector T cell function in inflamed tissues and contributes, in
part, to pathogen clearance.
DISCUSSION
Here we identify αv (with β1 or β3) as a key receptor for intradermal motility of effector
CD4+ T cells. Integrin-dependency in interstitial motility of leukocytes has been
controversial with previous studies supporting a largely integrin-independent mode of
migration5,6. However, more recent studies suggest migration modes appear to be highly
dynamic, with dendritic cells seamlessly moving between integrin-dependent and integrin-
independent motility39, 40. Thus the requirement for integrin-driven motility is likely to be
context-dependent and influenced by inflammation-induced changes in the tissue
microenvironment. We found that T cells are essentially non-motile in non-inflamed tissue
but motility is dramatically enhanced during inflammation in a manner dependent on
integrins αvβ1 and/or αvβ3. In the CFA-inflamed dermis, significant structural changes in the
density and composition of the tissue extracellular matrix occur, which may create an
environment where lymphocytes are dependent on integrins for motility. Integrin specificity
appears to be coordinately regulated with the type of ECM changes in the inflamed tissue.
Fibronectin has long been known to bind to collagen and serve as a cell adhesion substrate32
and we speculate that the inflammation-driven increase in fibronectin of the dermal
interstitium observed across species29–31 provides a substrate for infiltrating lymphocytes.
Intriguingly, TH1 effector cells are unique among leukocytes in their ability to synthesize
fibronectin41 possibly suggesting an active role for effector T cells in contributing to
substrate deposition to facilitate interstitial migration. Our data show that the upregulation of
αv can be initiated during T cell activation in the LN, although further selection or
regulation of integrin-expressing cells may occur locally as the effector T cells enter the
inflamed microenvironment. Using IV-MPM, we found that the expression of αv is critical
for the rapid amoeboid movement of effector T cells in the inflamed dermis and that
perturbation of αv limits T cell effector function and attenuates efficient L. major clearance.
Chemokines direct tissue-specific homing and localization within tissues and are critical for
the activation of leukocyte integrins (LFA-1, Mac-1) for firm adhesion during
transendothelial migration (TEM). Although not directly tested here, we speculate that the
integrin-dependent interstitial movement in the dermis is also contingent on chemokines for
integrin activation. Indeed, many studies show a requirement for pertussis toxin-sensitive G-
protein coupled receptors for interstitial motility. Lymphocyte crawling during TEM occurs
via the dynamic assembly-disassembly of high affinity LFA-1 in adhesive filopodia and is
essential for crawling under shear flow42, 43. Future studies with fluorescently-tagged αv
should reveal the dynamics of αv expression in migrating T cells in inflamed tissues. During
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tTEM, shear forces promote migration through increases in invasive filopodia and
accelerated dissociation of LFA-1:ICAM-1 interactions42. The edema associated with
inflammation in tissues may also elevate ‘interstitial’ shear forces to promote integrin-
dependent motility44. It is also possible that integrin activation could be regulated
independently of chemokines, perhaps via CD44 as observed for TEM. Alternatively, it is
possible that the integrin dependency underlies a need to adhere to ECM fibers to come into
contact with immobilized chemokines rather than direct integrin-driven motility: disrupting
integrin adhesion to ECM fibers could lead to an inability of cells to follow haptotactic
gradients imposed by chemokines coating the fibers.
Integrins play a variety of roles in the immune response including promoting stable T cell-
DC interactions for effector function, extravasation and tissue retention or survival. Distinct
integrins direct tissue-specific homing (α4β7 integrin and gut accumulation) and may
determine location within the tissue as suggested by T cell α1-integrin expression and their
accumulation in the epidermis in the lung and skin33,45. Our data highlight an essential role
for integrins in T cell movement through the inflamed tissue and suggest specific integrin
expression is dictated by the changes in ECM components. As concluded from in vitro
models2, the density of the ECM scaffold may also influence the mode of motility with the
degree of confinement dictating the utility of non-adhesive actin-myosin-based movement
versus adhesive integrin-based migration4. Thus the mode of motility at sites of
inflammation may differ depending on the extent of ECM remodeling, density or
composition.
Interestingly, αv itself plays a critical role in shaping the inflammatory microenvironment
through modulating cytokine and matrix expression. αv-binding to latent TGF-β via its RGD
motif leads to TGF-β release from the ECM and biological activation46 important in wound
healing and fibrotic events. αv also modulates induction of TH17 and Treg differentiation via
changes in dendritic cell function47–49. More recently the IL-4 and IL-13-induced
matricellular protein, periostin50, binds αv integrin on keratinocytes to induce
proinflammatory cytokines. Blockade of either periostin or αv potently suppressed the
allergic skin inflammation. Indeed, blockade or genetic ablation of αv (mainly in myeloid
cells) can inhibit inflammation in EAE, allergic asthma and lung scleroderma47, 48, 51
although it precipitates ulcerative colitis52. The requirement for αv for effector T cell
interstitial migration through such inflamed sites may compound the therapeutic effects of
targeting the αv pathway in inflammation. Interestingly, this αv-based motility is not
required for gain of effector function or localization to the dermis but does limit robust
execution of effector function, suggesting attenuation of interstitial migration limits the
ability of effector T cells to scan the microenvironment of the inflamed tissue in search of
specific antigen-bearing APCs.
Acute disruption of αv via antibody blockade or shRNA knockdown revealed functional
requirements for αv in T cell interstitial motility. However, these were not recapitulated by
genetic ablation experiments, with αv-deficient T cells remaining highly motile through a
compensatory mechanism dependent on RGD-binding integrins or other RGD-binding
proteins. A similarly high degree of functional compensation for fibronectin-binding integrin
subunits in knockout mice has been reported for developmental roles of αv and α5
53, 54 and
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talso for β1 and β3 in knockout cell lines55. These data therefore suggest a fundamental
requirement for integrin-fibronectin (or other RGD-containing matrix proteins) interactions
during both development and immune cell migration during inflammation.
Here we have show that inflammation in the dermis necessitates an integrin-based
mechanism for effector T cell interstitial migration that is critical for full effector T cell
function in the inflamed and infected tissue. As an intriguing perspective, it may be possible
to predict the integrin requirements for interstitial migration in a given inflamed tissue by
identifying the specific changes to the ECM landscape. Understanding the coordinate
expression of leukocyte integrins and ECM substrates within inflamed tissues should
provide novel therapeutic strategies for inflammation-specific and/or tissue-specific
mitigation of immune-mediated tissue damage in autoimmunity and chronically inflamed
pathologies.
On-line METHODS
Mice, Immunizations, and Infections
BALB/c and C57BL/6 mice were purchased from National Cancer Institute. LACK-specific
TCR-Tg WT15 mice and IFN-γ reporter (Yeti) mice were provided by Drs. Nigel Killeen
and Richard Locksley, respectively. CD11c-YFP mice were provided by Dr. Michel
Nussenzweig. itgb1fl/fl mice. Albino B6 mice and Gt(ROSA)26Sortm1(EYFP)Cos mice were
purchased from Jackson Laboratories and CD4-Cre mice from Taconic Farms. itga5fl/fl mice
provided by Dr. Richard Hynes. itgavfl/fl mice were provided by Dr Adam Lacy-Hulbert.
Mice were bred and maintained in the pathogen-free animal facility at the University of
Rochester. All animal procedures were approved by the Institutional Animal Care and Use
Committee of the University of Rochester. Mice were immunized intradermally in the ear
with 1 µg pLACK, 1 µg pOVA, or 5 ug Keyhole Limpit Hemacyanin (KLH) emulsified in
Complete Freund’s Adjuvant (CFA). For Leishmania major infection, mice were infected
subcutaneously in the ear with 2 × 105 infectious parasites/ear. For Influenza infection,
C57BL/6 mice were sedated with avertin and given a 30 uL intranasal inoculation of
Influenza A/HK/X31 (9.2×107 PFU/ml). Eight days after infection, lungs were perfused and
airway-resident cells were removed by bronchoalveolar lavage. Lymphocytes were then
isolated from the lung tissue by collagenase digestion and Ficoll separation of viable cells.
For H. polygrus infection, C57BL/6 mice were infected by gavage with 200 L3
Heligmosomoides polygyrus larvae. Ten days later, lamina propria lymphocytes were
extracted from the small intestines using collagenase and a Percoll gradient after removal of
Peyer's Patches. For tape-stripping, the ventral skin of the ear was tape stripped 10× by
applying and gently removing adhesive tape (Scotch brand 610) followed by the application
of 50µg OVA protein in 10uL PBS directly onto the stripped ear surface. Ears were
harvested 5 days after tape stripping. For chronic allergic dermal sensitization, the ears were
tape stripped three times, spaced three weeks apart. Samples were collected 48 hours after
the final tape stripping and application of OVA. For the pancreas, diabetic NOD mice were
identified when blood glucose levels exceeded 300mg/dl (usually 10–12 weeks of age).
Young (6 weeks) non-diabetic mice were used as controls. Cells were isolated from the
pancreas following collagenase digestion as for the ear dermis.
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All conjugated antibodies were purchased from eBioscience or Biolegend unless otherwise
noted. For integrin expression on transferred WT15 T cells in the dermis, leukocytes were
extracted from the ear and stained with CD45-Pacific Blue, CD4-AlexaFluor700, Thy-1.1-
FITC and antibodies against one of the following: β1-PE (Hmβ1-1), α1-Alexa 488 or α2-
FITC (Ha31/8 and Ha1/29, respectively), α3-APC (polyclonal, R&D Systems), α4-PE
(R1-2), purified α5 (5H10-27), α6-APC (GoH3) and αv-PE (Hmα5-1 or RMV-7). Note that
the anti-αv specificity of the commercially available Hmα5-1 antibody clone (Biolegend) is
different from that of the originally-described anti-α5 clone (see supplementary Fig 10).
Hmα5-1 binds to CD4+ T cells from itga5fl/fl CD4-Cre+ mice but not itgavfl/fl CD4-Cre+
mice (Fig 13a) and precipitates αv but not α5 from activated T cell lysates (Fig 13b).
Moreover, the Biolegend Hmα5-1 clone competes for binding with commercially available
anti-αv clone, RMV-7 (Supplementary Fig 10). Expression of α5 on in vitro activated CD4+
T cells was used to determine the specificity of Biolegend Hmα5-1 clone as expression of
α5 could not be detected on T cells activated in vivo (Supplementary Fig 10) under the
variety of stimulatory conditions outlined in Fig 5. Of note, the absence of α5 staining in
vivo was not due to an α5-specific sensitivity to enzymatic tissue digestion as positive α5
staining on CD11b+ myeloid cells remained intact with/without enzymatic digestion (data
not shown). Supplementary figure 10 directly compares the α5-integrin specificity of the
Biolegend Hmα5-1 clone and the original anti-α5 clone from Yagita. For blocking in vivo,
the following azide-free low endotoxin antibodies were injected through a tail vein catheter:
anti-β1 (Hmβ1-1, eBioscience), anti-α1 (Ha31/8), anti-α2(Ha1/29), anti-α4 (R1-2,
Biolegend), anti-αv (HMα5-1, Biolegend), anti-αL (M17/4), and control Armenian Hamster
IgG (H4/8). For FACS, cells were analyzed on an LSR II or a FACSCalibur (BD
Biosciences, San Jose, CA). Data analyzed using FlowJo software (TreeStar).
Cell Culture and Adoptive Transfers
For in vitro TH1 priming, CD4+ cells were enriched from lymph node and spleen from
WT15 Tg mice by complement-mediated lysis of CD8+ (3.155), CD24+ (J11D), and MHC-
II+ (M5/114) cells. Naïve T cells were then enriched by positive selection for CD62L+ cells
using a MACS column (Miltenyi Biotec): routinely >85% CD4+ and >95% CD62L+. Naïve
T cells were stimulated with peptide-pulsed irradiated T cell-depleted splenocytes, IL-2 (10
U/mL), IL-12 (20 ng/mL), and anti-IL-4 (11B11, 40 µg/mL). Cells were split three days
later and harvested on day five. The effector TH1 cells were labeled with CFSE (Invitrogen,
Carlsbad, CA) and transferred into mice (5×106 cells per mouse) prior to immunization. For
WT15-Yeti cells, naïve CD4+ T cells were enriched as described above and transferred
directly into BALB/c mice without in vitro stimulation or labeling. The following day, mice
were immunized with 5 µg pLACK/CFA in the ear dermis.
Extraction of T cells from the ear dermis
Ear tissue was processed as previously described33. Ears were excised, ventral and dorsal
sheets separated and placed in collagenase D (1 mg/ml in PBS with 3mM CaCl2, Roche) and
incubated for 30 minutes at 37°C. EDTA was added (5mM) and the digested tissue
disrupted using a pestle and metal strainer. Insoluble material was removed by filtration and
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tthe pellet was washed twice in HBSS with 5% FCS. For ex vivo intracellular cytokine
staining, Brefeldin A (1µg/ml) was added to all extraction and wash buffers to block
cytokine secretion.
Intravital Multiphoton Microscopy and Image Analysis
Mice were anesthetized with isoflurane (induction ~5%, maintenance ~1.5%) (isoflurane
vaporizer/ventilation machine, Lei Medical M3000R, VAP2100). Once anesthetized, a
venous catheter was inserted in the lateral tail vein and the ventral side of the ear pinna was
affixed to a coverslip. Mice were placed on a custom-made platform for imaging. Body
temperature was maintained using a heated water pad and a heating block, monitored with a
rectal thermometer. The microscope objective was heated (Bioptechs) to maintain normal
dermal temperature during imaging. Images were acquired using an Olympus FV1000-AOM
multiphoton system. Fluorescence was collected using an Olympus XLPlanN 25× NA1.05
objective for deep tissue multiphoton imaging and detected using two proprietary external
photomultipliers (Hamamatsu, Japan). Fluorescence excitation was achieved by a Spectra-
Physics DeepSee-MaiTai HP Ti:Sa laser tuned to 900 nm for excitation of CFSE and Texas
Red. CFSE and Texas Red fluorescence was collected using 519/26nm and 607/36nm
bandpass filters (Olympus and Semrock, respectively). YFP fluorescence was collected
using 535/30nm bandpass filter (Chroma). Second harmonic signals were collected using a
447/60nm bandpass filter (Semrock). Z-stack images (512×512 pixels) were acquired with a
vertical resolution of 3–5 µm and a lateral pixel size of 994nm. For time series, three-
dimensional stacks were acquired every 40–45 seconds with a Kalman filter.
Raw imaging data were processed with Volocity software (Perkin Elmer) and ImageJ. A
median filter was used to reduce noise and T cells were tracked using automated algorithms
with manuals corrections. Raw tracking data was exported and processed in Excel. Cell
tracks lasting for less than eight minutes were excluded from analyses. No minimum cell
displacement criteria were imposed that would have excluded non-motile cells. Movies were
created using both Volocity and ImageJ. For analysis of the effects of blocking antibodies,
images were acquired for 20 minutes prior to treatment, followed by 25 minutes following
treatment.
For quantitative analysis of collagen density, SHG images were obtained from the dermis of
anesthetized mice that had been immunized three days previously in one ear with KLH/
CFA. Control images were taken from the contralateral ear. Images stacks were taken at
512×512 resolution (994 nm/pixel) at 1 µm vertical intervals through the ear. Laser
intensities and PMT voltages were adjusted with tissue depth to maintain visible SHG
signal. Once acquired, 150×150 µm regions of the image stacks were selected to avoid hair
follicles and major vasculature.
Analysis tool for migrating T cell—ECM association—ECM-fiber directions were
estimated using ImageJ. The Differentials plug-in was used to calculate intensity gradients,
which were rotated by 90 degrees and mapped to a range of [0..180] degrees to represent
fiber directions. Our approach took advantage of the fact that the direction of strongest
variation (intensity gradients) must be perpendicular to the fiber direction: any directions
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tpointing away from the fiber have a lower intensity than the directions that follow the fiber.
We only determined lateral directions for this analysis (Fig 3a,b), since both T-cell
movement and ECM-fiber direction are preferentially aligned in the X-Y plane
(Supplementary Fig. 2,4,5). Cell locations were imported from tracking data and used to
export fiber directions and gradient magnitudes from spheres with 6 µm radius around cell
centroids. Extracted ECM-direction data and cell tracks were imported in R. Cell velocities
were calculated using central differences and tracks with sedentary cells, which were
defined as cells with a mean velocity of less than 2.5 µm/min were removed. For each
observation of a cell in a track, we disregarded irrelevant direction samples stemming from
background noise instead of ECM-fibers by considering only those samples that were in the
90th percentile of the intensity gradient magnitude (Supplementary Fig 5). The local ECM-
direction around the cell centroid was calculated as the gradient weighted mean of the
selected direction samples.
FTY720 Treatment
Mice received FTY20 (1 mg/kg, Cayman Chemicals) i.p. 72 and 96 hours post-
immunization. Control mice received vehicle alone.
RGD Peptide Treatment
BALB/c mice received CFSE-labeled effector TH1 cells and were immunized as described
above. Immediately prior to imaging, RGD or control RAD peptide was injected directly
into the ear dermis (50 µg peptide, Peptides International).
Immunohistochemistry
Three days after immunization, ears were excised and frozen in OCT. Frozen sections were
cut, fixed, and stained for ECM components. Primary antibodies against fibronectin
(Abcam) and types I, III, and IV collagen (Southern Biotec) were used, followed by staining
with Cy3- and AlexaFluor647-conjugated secondary antibodies (Jackson and Molecular
Probes, respectively). For IHC analysis of influenza-infected lung tissue, lungs were excised
eight days post-infection.
Retroviral Transduction
Naive β1−/− OT-II cells were purified from spleen and LN and stimulated with peptide/APC
under TH1 conditions. One day after the initiation of the culture, cells were transduced with
MSCV encoding αv shRNA or MSCV vector alone. Cells were then split on day 3 and
harvested on day 5, similar to conditions with WT15 cells. On the day of harvest,
transduction efficiency (indicated by % GFP+ cells) and αv expression levels were measured
by FACS. Transduction efficiencies were routinely between 15–30% and were similar
between control vector and αv shRNA MSCV.
Statistics
All statistical tests were done with GraphPad Prism or R software. Many analyses used the
non-parametric Mann Whitney U test. For multiple analyses of variance, the Kruskal-Wallis
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ttest was used with Dunn’s post-test. For pairwise comparisons, Wilcoxon signed-rank test
was used. ANOVA was used across multiple treatment groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors thank Ron Germain and Jackson Egen for technical assistance; Karl Kasischke, Linda Callahan, Ed
Brown and the URMC Multiphoton Core for support; Beatriz Leon and Frances Lund for H.polygyrus infected
tissue; Kihong Lim for technical assistance; Jim Miller and Steve Georas for comments on the manuscript; and
members of the Fowell and Kim labs for discussion and support. This work was supported by National Institutes of
Health grants AI072690 and AI088427 to D.J.F, HL018208 and HL087088 to M.K, AI089079 to M.G.O, and
American Heart Association grant 11SDG7520018 to Y-M.H.
REFERENCES
1. Nourshargh S, Hordijk PL, Sixt M. Breaching multiple barriers: leukocyte motility through venular
walls and the interstitium. Nat Rev Mol Cell Biol. 2010; 11:366–378. [PubMed: 20414258]
2. Friedl P, Weigelin B. Interstitial leukocyte migration and immune function. Nat Immunol. 2008;
9:960–969. [PubMed: 18711433]
3. Friedl P, Entschladen F, Conrad C, Niggemann B, Zanker KS. CD4+ T lymphocytes migrating in
three-dimensional collagen lattices lack focal adhesions and utilize beta1 integrin-independent
strategies for polarization, interaction with collagen fibers and locomotion. Eur J Immunol. 1998;
28:2331–2343. [PubMed: 9710211]
4. Jacobelli J, et al. Confinement-optimized three-dimensional T cell amoeboid motility is modulated
via myosin IIA-regulated adhesions. Nat Immunol. 2010; 11:953–961. [PubMed: 20835229]
5. Woolf E, et al. Lymph node chemokines promote sustained T lymphocyte motility without
triggering stable integrin adhesiveness in the absence of shear forces. Nat Immunol. 2007; 8:1076–
1085. [PubMed: 17721537]
6. Lammermann T, et al. Rapid leukocyte migration by integrin-independent flowing and squeezing.
Nature. 2008; 453:51–55. [PubMed: 18451854]
7. Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol. 2010;
10:712–723. [PubMed: 20865019]
8. Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-
selective lymphocyte trafficking. Nat Immunol. 2008; 9:981–987. [PubMed: 18711435]
9. Ray SJ, et al. The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated
immune protection against heterologous influenza infection. Immunity. 2004; 20:167–179.
[PubMed: 14975239]
10. Okada T. Two-photon microscopy analysis of leukocyte trafficking and motility. Semin
Immunopathol. 2010; 32:215–225. [PubMed: 20603709]
11. Schumann K, et al. Immobilized chemokine fields and soluble chemokine gradients cooperatively
shape migration patterns of dendritic cells. Immunity. 2010; 32:703–713. [PubMed: 20471289]
12. Bajenoff M, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in
lymph nodes. Immunity. 2006; 25:989–1001. [PubMed: 17112751]
13. Wilson EH, et al. Behavior of parasite-specific effector CD8+ T cells in the brain and visualization
of a kinesis-associated system of reticular fibers. Immunity. 2009; 30:300–311. [PubMed:
19167248]
14. Matheu MP, et al. Imaging of effector memory T cells during a delayed-type hypersensitivity
reaction and suppression by Kv1.3 channel block. Immunity. 2008; 29:602–614. [PubMed:
18835197]
Overstreet et al. Page 14
Nat Immunol. Author manuscript; available in PMC 2014 September 09.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t15. Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S. In vivo imaging of cytotoxic T
cell infiltration and elimination of a solid tumor. J Exp Med. 2007; 204:345–356. [PubMed:
17261634]
16. Mrass P, et al. Random migration precedes stable target cell interactions of tumor-infiltrating T
cells. J Exp Med. 2006; 203:2749–2761. [PubMed: 17116735]
17. Werr J, Xie X, Hedqvist P, Ruoslahti E, Lindbom L. beta1 integrins are critically involved in
neutrophil locomotion in extravascular tissue In vivo. J Exp Med. 1998; 187:2091–2096.
[PubMed: 9625769]
18. Gray EE, Suzuki K, Cyster JG. Cutting edge: Identification of a motile IL-17-producing
gammadelta T cell population in the dermis. J Immunol. 2011; 186:6091–6095. [PubMed:
21536803]
19. Sumaria N, et al. Cutaneous immunosurveillance by self-renewing dermal gammadelta T cells. J
Exp Med. 2011; 208:505–518. [PubMed: 21339323]
20. Wang Q, et al. CD4 promotes breadth in the TCR repertoire. J Immunol. 2001; 167:4311–4320.
[PubMed: 11591754]
21. Filipe-Santos O, et al. A dynamic map of antigen recognition by CD4 T cells at the site of
Leishmania major infection. Cell Host Microbe. 2009; 6:23–33. [PubMed: 19616763]
22. Egawa G, et al. In vivo imaging of T-cell motility in the elicitation phase of contact
hypersensitivity using two-photon microscopy. J Invest Dermatol. 2011; 131:977–979. [PubMed:
21248770]
23. Stetson DB, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised
for rapid effector function. J Exp Med. 2003; 198:1069–1076. [PubMed: 14530376]
24. Ng LG, et al. Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS
Pathog. 2008; 4:e1000222. [PubMed: 19043558]
25. Springer TA. Adhesion receptors of the immune system. Nature. 1990; 346:425–434. [PubMed:
1974032]
26. Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb
Perspect Biol. 2011; 3
27. DeNucci CC, Shimizu Y. beta1 integrin is critical for the maintenance of antigen-specific CD4 T
cells in the bone marrow but not long-term immunological memory. J Immunol. 2011; 186:4019–
4026. [PubMed: 21357540]
28. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;
12:697–715. [PubMed: 8970741]
29. Clark RA, Dvorak HF, Colvin RB. Fibronectin in delayed-type hypersensitivity skin reactions:
associations with vessel permeability and endothelial cell activation. J Immunol. 1981; 126:787–
793. [PubMed: 7005343]
30. Clark RA, et al. Fibronectin deposition in delayed-type hypersensitivity. Reactions of normals and
a patient with afibrinogenemia. J Clin Invest. 1984; 74:1011–1016. [PubMed: 6381536]
31. Kusubata M, et al. Spatiotemporal changes of fibronectin, tenascin-C, fibulin-1, and fibulin-2 in
the skin during the development of chronic contact dermatitis. J Invest Dermatol. 1999; 113:906–
912. [PubMed: 10594729]
32. Klebe RJ. Isolation of a collagen-dependent cell attachment factor. Nature. 1974; 250:248–251.
[PubMed: 4859375]
33. Richter M, et al. Collagen distribution and expression of collagen-binding alpha1beta1 (VLA-1)
and alpha2beta1 (VLA-2) integrins on CD4 and CD8 T cells during influenza infection. J
Immunol. 2007; 178:4506–4516. [PubMed: 17372009]
34. Campbell DJ, Butcher EC. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T
cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med. 2002; 195:135–141.
[PubMed: 11781372]
35. Sigmundsdottir H, et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction
to the epidermal chemokine CCL27. Nat Immunol. 2007; 8:285–293. [PubMed: 17259988]
36. Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG. The function of follicular
helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol. 2009;
10:375–384. [PubMed: 19252493]
Overstreet et al. Page 15
Nat Immunol. Author manuscript; available in PMC 2014 September 09.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t37. McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen presentation drives
simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity.
2009; 30:277–288. [PubMed: 19200757]
38. Sojka DK, Fowell DJ. Regulatory T cells inhibit acute IFN-gamma synthesis without blocking T-
helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10. Proc Natl
Acad Sci U S A. 2011; 108:18336–18341. [PubMed: 22025707]
39. Renkawitz J, et al. Adaptive force transmission in amoeboid cell migration. Nat Cell Biol. 2009;
11:1438–1443. [PubMed: 19915557]
40. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol. 2010;
188:11–19. [PubMed: 19951899]
41. Sandig H, et al. Fibronectin is a TH1-specific molecule in human subjects. J Allergy Clin
Immunol. 2009; 124:528–535. 535 e521–525. [PubMed: 19541353]
42. Shulman Z, et al. Lymphocyte crawling and transendothelial migration require chemokine
triggering of high-affinity LFA-1 integrin. Immunity. 2009; 30:384–396. [PubMed: 19268609]
43. Park EJ, et al. Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and
interstitial migration in lymph nodes. Blood. 2010; 115:1572–1581. [PubMed: 20023213]
44. Rutkowski JM, Swartz MA. A driving force for change: interstitial flow as a morphoregulator.
Trends Cell Biol. 2007; 17:44–50. [PubMed: 17141502]
45. Conrad C, et al. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the
development of psoriasis. Nat Med. 2007; 13:836–842. [PubMed: 17603494]
46. Yang Z, et al. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the
phenotype of TGFbeta1-null mice. J Cell Biol. 2007; 176:787–793. [PubMed: 17353357]
47. Luzina IG, et al. Regulation of pulmonary inflammation and fibrosis through expression of
integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes. Arthritis Rheum. 2009;
60:1530–1539. [PubMed: 19404954]
48. Acharya M, et al. alphav Integrin expression by DCs is required for Th17 cell differentiation and
development of experimental autoimmune encephalomyelitis in mice. J Clin Invest. 2010;
120:4445–4452. [PubMed: 21099114]
49. Paidassi H, et al. Preferential expression of integrin alphavbeta8 promotes generation of regulatory
T cells by mouse CD103+ dendritic cells. Gastroenterology. 2011; 141:1813–1820. [PubMed:
21745448]
50. Masuoka M, et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J
Clin Invest. 2012; 122:2590–2600. [PubMed: 22684102]
51. Kudo M, et al. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice
and enhances mouse and human airway smooth muscle contraction. Nat Med. 2012; 18:547–554.
[PubMed: 22388091]
52. Lacy-Hulbert A, et al. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav
integrins. Proc Natl Acad Sci U S A. 2007; 104:15823–15828. [PubMed: 17895374]
53. Yang JT, Hynes RO. Fibronectin receptor functions in embryonic cells deficient in alpha 5 beta 1
integrin can be replaced by alpha V integrins. Mol Biol Cell. 1996; 7:1737–1748. [PubMed:
8930896]
54. van der Flier A, et al. Endothelial alpha5 and alphav integrins cooperate in remodeling of the
vasculature during development. Development. 2010; 137:2439–2449. [PubMed: 20570943]
55. Wennerberg K, et al. Beta 1 integrin-dependent and -independent polymerization of fibronectin. J
Cell Biol. 1996; 132:227–238. [PubMed: 8567726]
Overstreet et al. Page 16
Nat Immunol. Author manuscript; available in PMC 2014 September 09.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 1. Migratory patterns of effector TH1 T cells in the CFA-inflamed ear dermis
(a) Maximum intensity projections across X, Y, and Z axes of WT15 T cells (green) and
collagen (second harmonic generation, blue) in the CFA-inflamed dermis. Scale bar, 40µm.
(b) X-Y projection of T cells and SHG with vasculature shown in red using intravenous
Texas Red-labeled dextran. (c) Steady-state (non-inflamed, Non-Inf) and CFA-inflamed
(Inf) T cell motility by average velocity, displacement and meandering index. (d) X–Y
projections of the T cell migration tracks over a 20-minute time span with CFA. (e) Mean
squared displacement (MSD) of the T cell tracks show a linear increase over time. (f)
Comparison of average velocities of T cells using adoptively transferred effector WT15 T
cells (in vitro) or effector T cells primed in vivo using WT15 IFN-γ-YFP reporter cells to
identify putative IFN-γ-producing cells (in vivo). Statistics by Mann-Whitney: ***p<0.001;
NS, not significant, p>0.05. Data are representative of more than ten independent imaging
experiments.
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tFigure 2. T cells migration is guided by ECM-fibers
BALB/c mice immunized with KLH/CFA in the ear dermis and analyzed by IV-MPM on
day 3. Collagen structure by SHG. (a) Sample image volumes of non-immunized (Ctrl) and
CFA-inflamed ears. (b) Analysis of planar area (XY) (left) and cross-sectional area (XZ)
filled by SHG in control and CFA-inflamed ears. Left, each circle represents a unique region
(150 µm × 150 µm area, avoiding hair follicles and blood vessels) from three different ears
for each group. Right, each circle represents one of three orthogonal views analyzed for
every one planar region analysis on the left. Bars represent mean ± SEM. (c) Cross-sectional
images of SHG signal intensity in ear (top) and SHG across the vertical yellow lines
(bottom). (d) Projection of cell tracks in x-y plane. Color code, frame at which T cell
locations were observed. (e) Reconstructed fiber directions. (f) Migration and fiber
directions along eight representative T-cell tracks. Directions are measured as angle relative
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tto the x-axis of the image data: blue dots, T cell tracks; red dots, fibers. (g) Angle
differences between fiber and migration directions in (f). (h) Histogram of angle differences
for all tracks time steps from a single representative experiment (blue) compared to the
distribution of angle differences that would result from random migration (grey). (i)
Frequency of directional differences smaller than 15° and 30°, n=10 experiments. Statistical
significances evaluated by Mann-Whitney: **p<0.01; ***p<0.001.
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tFigure 3. RGD-dependent integrin blockade impairs T cell motility in the inflamed dermis
(a, b) While imaging WT15 T cells in the inflamed ear dermis, control (Ctrl) IgG or a
blocking antibody to β1 integrin were administered intravenously. (a) XY projections of T
cell migratory paths over 25 minutes immediately following control IgG or anti-β1 integrin
treatment (100 µg antibody). (b) Average velocity of T cells. (c) WT or β1-deficient
(itgb1fl/fl × CD4-Cre+) OT-II T cells were imaged in the dermis and the resultant T cell
crawling patterns are shown. (d) Blocking antibodies to β1 integrin were administered
intravenously and OT-II T cell migration velocities shown for both WT and β1-deficient
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tcells. (e) β1-deficient T cell migration velocities after blocking antibodies to β3 integrin. (f–
g) While imaging WT OT-II T cells in the dermis, blocking antibodies to β3 integrin were
administered intravenously and the resultant T cell crawling patterns (f) and migration
velocities (g) are shown. (h–j) Immediately prior to imaging of adoptively transferred WT
effector WT15 T cells, control RAD or integrin-blocking RGD peptides were injected into
the CFA-inflamed ear dermis. (h) XY projections of T cell migratory paths over 25 minutes.
(i) Average velocity of T cells over the same time period. (j) Immediately prior to imaging
of WT and β1-deficient OT-II T cells in the inflamed dermis, control RAD or blocking RGD
peptides were injected into the ear dermis and resultant T cell migration velocities are
shown. Statistics by Mann-Whitney: ***p<0.001; NS, not significant, p>0.05.
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tFigure 4. CD4+ T cells utilize αv integrin for intradermal motility
(a) Integrin expression by in vivo-primed WT15 cells in the immunized ear dermis and
draining lymph node five days after immunization. Histograms represent viable donor
CD4+Thy-1.1+ (WT15) lymphocytes: integrin staining (black line) and isotype control
staining (grey shaded). (b,c) While imaging effector WT15 T cells in the inflamed ear
dermis, control (Ctrl) IgG or blocking antibodies (100 µg each) to the indicated integrin
subunits were administered intravenously. XY projections of T cell migratory paths over 25
minutes immediately following treatment with indicated blocking antibody. c. Average
velocities of T cells over the same time periods and treatments. (d) Immunohistological
staining of fibronectin on frozen sections of control (non-inflamed, Ctrl) and KLH/CFA-
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timmunized ears three days after immunization. Scale bar, 25µm. (e) Co-staining of
fibronectin and types I or III collagen on KLH/CFA-inflamed ears. Scale bar, 10µm. Data
are representative of at least three independent experiments for all antibody-blocking
experiments. For (c) statistical significance was evaluated by a Kruskal-Wallis test with
Dunn’s post-test; *** p<0.001.
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tFigure 5. Broad αv integrin expression by effector CD4+ T cells across tissues and types of
inflammation
(a) Histogram profiles of αv integrin expression on total CD4+ T cells extracted from the ear
dermis (top) and other tissues (bottom). Where indicated, αv expression on CD4+ T cells
from non-inflamed (control) tissues are shown (blue line), compared to inflamed/infected
tissue (red line) and isotype control staining (grey shaded). (b) Hierarchical clustering of the
frequency of integrin-expressing T cell populations from different tissues. (c) Histogram
expression profiles of indicated alpha chain integrin subunits on CD4+ T cells extracted
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tfrom influenza-infected lung tissue (day 8 post-infection) compared to isotype control
staining (grey shaded). (d) Comparison of fibronectin and collagen immunohistochemistry
on tissues from influenza-infected lung (day 8) (top row) and CFA-inflamed dermis (bottom
row). Second panels are larger representations of boxed areas from first panel. Third panel is
a DIC image of same boxed area.
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tFigure 6. LN “emigrant” effector T cells express high levels of αv integrin
Naïve WT15 cells were transferred into BALB/c mice that were then immunized with
pLACK/CFA (LACK-CFA Inf) in ear dermis the following day or not immunized (Non-
inf). (a) αv integrin and CD62L expression on WT15 cells in the draining lymph node and
ear dermis five days after immunization. Numbers represent cell frequency (%). The red box
highlights the αv
hi CD62Llo population throughout all panels in the figure. (b) Expression of
αv on activated cells in the draining lymph node. Transferred cells gated on high or low
expression of CD25 (left panel) and analyzed for αv and CD62L. (c, d) FTY720 (or vehicle)
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twas administered days 3 and 4 post-immunization and αv and CD62L expression was
evaluated on WT15 cells in the lymph node on day five. (d) Total numbers of WT15 cells in
the draining lymph node and immunized ear dermis in mice treated with FTY720 (open
bars) or vehicle (filled bars). Bars represent mean ± SEM. For (d) statistical significance
was evaluated by a Mann-Whitney test: * p<0.05; NS, not significant, p>0.05. Data are
representative of two independent experiments with similar results. n= 4–5 mice per group
per experiment.
Overstreet et al. Page 27
Nat Immunol. Author manuscript; available in PMC 2014 September 09.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 7. Non-redundant role for αv in effector CD4+ T cell intradermal motility and anti-
microbial clearance
(a) αv-deficient (itgavfl/fl × CD4-Cre+) OT-II T cell average velocity in CFA-inflamed
dermis and blockade with RGD peptides as in Fig 3. (b) β1-deficient OT-II T cell velocity in
the CFA-inflamed ear after anti-αv antibody. (c) TH1-primed β1-deficient OT-II T cells
transduced with MSCV-GFP encoding shRNA for αv integrin (αv shRNA) or empty vector
(Vector). Left, surface expression of αv integrin day 4 after retroviral transduction on GFP+
and GFP- cells, with two αv antibody clones or isotype control(grey). Right, αv MFI of GFP
+ and GFP- cells, normalized to the MFI of αv on untreated T cells. Bars represent mean ±
SEM, four independent experiments. (d–i) Transduced T cells transferred to C57BL/6 mice
and mice immunized intra-dermally with pOVA-CFA in one ear and KLH-CFA in the other
ear (no cognate antigen, No Ag). Transduced T cells (GFP+) in the ear dermis imaged by
IV-MPM day 3. (d) Number of vector or αv shRNA GFP+ T cells in the antigen-bearing
dermis. (e) Dermal location of effector T cells following co-injection of SNARF-labeled WT
(red) and GFP+ expressing αv shRNA (green) cells to pOVA-CFA immunized mice. (f) ex
vivo αv expression on dermal GFP+ cells. Black line, control vector; red line, αv shRNA. (g)
XY projections of T cell migration patterns and average velocities (h) (30 minutes). (i)
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tVector control and αv shRNA GFP+ expression in pOVA-CFA inflamed ears (left). Right,
frequency of IFNγ producing vector or αv shRNA GFP+ TH1 cells, gated as in dot plots, by
ex vivo intracellular cytokine staining for IFN-γ. No Ag, frequency of IFN-γ+-transferred
cells in KLH-OVA inflamed ears (j) Mice were infected with L. major in the ear dermis.
Four weeks post-infection, C57BL/6 mice were given anti-αv or control antibody i.p. (1mg/
mouse) three times/week for 3 weeks. Mice were harvested at week 7 post-infection and
CD4+ T cell numbers (j) and parasite load (k) determined in the infected ear dermis.
Statistics by Mann-Whitney: *p<0.05; **p<0.01; ***p<0.001; NS, not significant, p>0.05.
(k) ANOVA across C57BL/6 groups, p<0.0001 for parasite load.
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